Navigating The Prostate Cancer Frontier: A Bibliometric and Altmetric Analysis of [


Journal

Seminars in nuclear medicine
ISSN: 1558-4623
Titre abrégé: Semin Nucl Med
Pays: United States
ID NLM: 1264464

Informations de publication

Date de publication:
11 May 2024
Historique:
received: 08 04 2024
accepted: 20 04 2024
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 12 5 2024
Statut: aheadofprint

Résumé

The main aim of this study was to evaluate the current state of bibliometric and altmetric research output of [

Identifiants

pubmed: 38735824
pii: S0001-2998(24)00035-7
doi: 10.1053/j.semnuclmed.2024.04.004
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Akram Al-Ibraheem (A)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, 11942, Jordan; School of Medicine, University of Jordan, Amman, 11942, Jordan. Electronic address: aibraheem@khcc.jo.

Haneen Al-Abdallat (H)

School of Medicine, University of Jordan, Amman, 11942, Jordan.

Rakan Al-Rashdan (R)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, 11942, Jordan.

Ahmed Saad Abdlkadir (AS)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, 11942, Jordan.

Deya' Aldeen Sweedat (DA)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, 11942, Jordan.

Salem Fandi Alyasjeen (SF)

Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, 11942, Jordan.

Munir Ghesani (M)

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY.

Kalevi Kairemo (K)

Department of Molecular Radiotherapy and Nuclear Medicine, International Comprehensive Cancer Center Docrates, Saukonpaadenranta 2, FI-00180 Helsinki, Finland; Department of Nuclear Medicine, University of Texas, MD Anderson Cancer Center, Holcombe Blvd, 77030 Houston, TX.

John R Buscombe (JR)

Department of Nuclear Medicine, Cambridge University Hospitals, Cambridge, United Kingdom.

Classifications MeSH